BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:43 PM
 | 
Jun 24, 2010
 |  BC Extra  |  Company News

FDA panels to discuss Potiga, JZP-6

FDA advisory committees will discuss drug candidates from Valeant Pharmaceuticals International (NYSE:VRX) and Jazz Pharmaceuticals Inc. (NASDAQ:JAZZ) in August. The agency's Peripheral and Central Nervous System Drugs Advisory Committee will meet on Aug. 11 to discuss an...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >